GlobalData on MSN11h
JP Morgan 2025: Novartis streamlines its portfolio to drive future growth
Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.
Novartis AG (NVS) JPMorgan 43rd Annual Healthcare Conference (Transcript)
Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...